BridgeMD
New treatment option for Chronic Disease
Official title Impact of Mulstidisciplinary Medication Assessment Review in Surgery Departments
ClinicalTrials.gov ID: NCT03827031
What this study is testing
- What it's testing
- The presence of a clinical pharmacist (for their pharmacological expertise) and a general practitioner (for their somatic expertise) in surgery departments would contribute to improve the management of medications in elderly patients.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 65 and older
You may be able to join if
- The patient (or their representative) has given his consent and signed the consent form.
- The patient is affiliated to a health insurance programme.
- The patient is at least 65 years old (≥) treated by at least (≥) five medications for at least (≥) 6 months
- The patient is available for a follow-up of 3 months.
- The patient is hospitalized in the surgery department.
You likely can't join if
- The subject is participating in another category I treatment study.
- The subject is in an exclusion period determined by another study.
- The subject is under safeguard of justice.
- It is not possible to give the patient (or his/her trusted-person) informed information.
- Palliative care
See the full eligibility criteria
- The patient (or their representative) has given his consent and signed the consent form.
- The patient is affiliated to a health insurance programme.
- The patient is at least 65 years old (≥) treated by at least (≥) five medications for at least (≥) 6 months
- The patient is available for a follow-up of 3 months.
- The patient is hospitalized in the surgery department.
- Patient with a Trivalle score greater than or equal to 2 (≥).
- Patient living in a nursing home or going back home after hospitalization.
- The subject is participating in another category I treatment study.
- The subject is in an exclusion period determined by another study.
- The subject is under safeguard of justice.
- It is not possible to give the patient (or his/her trusted-person) informed information.
- Palliative care
The study team makes the final eligibility decision.
Where it's taking place
- Grenoble, France
- Montpellier, France
- Nîmes, France
- Toulouse, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 65 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Grenoble, France; Montpellier, France; Nîmes, France; Toulouse, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.